Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 7/20 | 0.62 |
| ▸ | TRPA1 | O75762 | 13/20 | 0.43 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.37 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | BACH1 | O14867 | 1/20 | 0.36 |
| ▸ | MAFK | O60675 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11576485 | 0.87 | — | — | |
| SCHEMBL483904 | 0.86 | — | — | |
| SCHEMBL18889093 | 0.81 | — | — | |
| SCHEMBL5098117 | 0.79 | — | — | |
| SCHEMBL5098134 | 0.77 | — | — | |
| SCHEMBL3629691 | 0.77 | MIF (1.00) | MIFTRPA1NAAAALDH1A1LMNA | |
| SCHEMBL1854857 | 0.72 | — | — | |
| SCHEMBL17261552 | 0.72 | — | — | |
| SCHEMBL484045 | 0.72 | MIF (0.68) | MIFTRPA1NAAAALDH1A1LMNA | |
| Ethylene Glycol SCHEMBL27861985 | 0.72 | MIF (0.39) | MIFTRPA1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240218018-A1 | Compstatin Analogs with Increased Solubility and Improved Pharmacokinetic Properties | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2024-07-04 | — | — | US | disclosed |
| US-11884747-B2 | Compstatin analogs with increased solubility and improved pharmacokinetic properties | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2024-01-30 | — | — | US | disclosed |
| WO-2023178239-A1 | HPSC-DERIVED ARTICULAR CHONDROCYTE COMPOSITIONS, SYSTEMS AND METHODS OF USE THEREOF | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2023-09-21 | — | — | WO | disclosed |
| EP-4011905-A2 | COMPSTATIN ANALOGS WITH INCREASED SOLUBILITY AND IMPROVED PHARMACOKINETIC PROPERTIES | The Trustees Of The University Of Pennsylvania (US) | 2022-06-15 | — | — | EP | disclosed |
| CN-105582523-B | Compstatin and analogs thereof for ocular disorders | 阿佩利斯制药公司 | 2022-04-15 | — | — | CN | disclosed |
| EP-3645550-B1 | COMPSTATIN ANALOGS WITH INCREASED SOLUBILITY AND IMPROVED PHARMACOKINETIC PROPERTIES | UNIV PENNSYLVANIA (US) | 2021-11-03 | — | — | EP | disclosed |
| US-11078461-B2 | Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products | THE JOHNS HOPKINS UNIVERSITY (US) | 2021-08-03 | — | — | US | disclosed |
| CN-112334477-A | Compstatin analogs with increased solubility and improved pharmacokinetic properties | 宾夕法尼亚大学理事会 | 2021-02-05 | — | — | CN | disclosed |
| US-10800812-B2 | Compstatin analogs with increased solubility and improved pharmacokinetic properties | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2020-10-13 | — | — | US | disclosed |
| US-20200188459-A1 | PROCESS FOR PREPARING METABOLIZED CONDITIONED GROWTH MEDIA | ALLERGAN INC (US) | 2020-06-18 | — | — | US | disclosed |
| WO-2001055212-A2 | DELIVERY OF THERAPEUTIC BIOLOGICAL FROM IMPLANTABLE TISSUE MATRICES | THE GENERAL HOSPITAL CORPORATION (US) | 2001-08-02 | — | — | WO | disclosed |
| US-6224893-B1 | WOUND HEALING AGENT | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2001-05-01 | — | — | US | disclosed |
| WO-2000069449-A2 | CONDITIONED CELL CULTURE MEDIUM COMPOSITIONS AND METHODS OF USE | ADVANCED TISSUE SCIENCES, INC. (US) | 2000-11-23 | — | — | WO | disclosed |
| US-6129761-A | Injectable hydrogel compositions | REPROGENESIS, INC. (US) | 2000-10-10 | — | — | US | disclosed |
| US-6096303-A | Method to enhance treatment of cystic tumors | MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE, INC. (US) | 2000-08-01 | — | — | US | disclosed |
| EP-1011633-A1 | SEMI-INTERPENETRATING OR INTERPENETRATING POLYMER NETWORKS FOR DRUG DELIVERY AND TISSUE ENGINEERING | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2000-06-28 | — | — | EP | disclosed |
| EP-0938343-A2 | TUMOR DELIVERY VEHICLES AND METHOD TO ENHANCE TREATMENT OF CYSTIC TUMORS | FBP Corporation (US) | 1999-09-01 | — | — | EP | disclosed |
| US-5945100-A | Tumor delivery vehicles | FBP CORPORATION (US) | 1999-08-31 | — | — | US | disclosed |
| WO-1998052543-A1 | SEMI-INTERPENETRATING OR INTERPENETRATING POLYMER NETWORKS FOR DRUG DELIVERY AND TISSUE ENGINEERING | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1998-11-26 | — | — | WO | disclosed |
| WO-1998004242-A2 | TUMOR DELIVERY VEHICLES AND METHOD TO ENHANCE TREATMENT OF CYSTIC TUMORS | FBP CORPORATION (US) | 1998-02-05 | — | — | WO | disclosed |